These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11769084)

  • 21. Incidental Pathogenic Variants in Renal Cell and Urothelial Carcinoma: Is It Time for Universal Screening?
    Jaime-Casas S; Yip W; Jeter JM
    JCO Precis Oncol; 2024 Jul; 8():e2400324. PubMed ID: 39088771
    [No Abstract]   [Full Text] [Related]  

  • 22. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
    Wu XR
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic associations of transitional cell carcinoma.
    Herring DW; Cartwright RA; Williams DD
    Br J Urol; 1979 Apr; 51(2):73-7. PubMed ID: 465977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The co-expression of antigen targets as a rationale for ADC combination in urothelial cancer.
    Bertucci F; de Nonneville A; Finetti P; Cohendet A; Guille A; Mamessier E
    Ann Oncol; 2024 May; 35(5):477-478. PubMed ID: 38364991
    [No Abstract]   [Full Text] [Related]  

  • 25. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
    Siefker-Radtke AO
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
    [No Abstract]   [Full Text] [Related]  

  • 26. Deceptively benign appearing urothelial carcinoma.
    Humphrey PA
    J Urol; 2014 Dec; 192(6):1817-8. PubMed ID: 25242396
    [No Abstract]   [Full Text] [Related]  

  • 27. Microsatellite instability and transitional cell carcinoma of the upper urinary tract.
    Rouprêt M; Azzouzi AR; Cussenot O
    BJU Int; 2005 Sep; 96(4):489-92. PubMed ID: 16104897
    [No Abstract]   [Full Text] [Related]  

  • 28. Urological cancers. Preface.
    McConkey DJ; Dinney C
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):267. PubMed ID: 20013034
    [No Abstract]   [Full Text] [Related]  

  • 29. Frequent phosphorylation at serine 392 in overexpressed p53 protein due to missense mutation in carcinoma of the urinary tract.
    Furihata M; Kurabayashl A; Matsumoto M; Sonobe H; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
    J Pathol; 2002 May; 197(1):82-8. PubMed ID: 12081208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
    Chung SD; Lai MK; Chueh SC
    BJU Int; 2008 Aug; 102(4):519. PubMed ID: 18699962
    [No Abstract]   [Full Text] [Related]  

  • 31. Promoter hypermethylation: a new therapeutic target emerges in urothelial cancer.
    Cote RJ; Laird PW; Datar RH
    J Clin Oncol; 2005 May; 23(13):2879-81. PubMed ID: 15753457
    [No Abstract]   [Full Text] [Related]  

  • 32. DNA hypomethylation on pericentromeric satellite regions significantly correlates with loss of heterozygosity on chromosome 9 in urothelial carcinomas.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 Jan; 173(1):243-6. PubMed ID: 15592089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histologic variants of infiltrating urothelial carcinoma.
    Zhai QJ; Black J; Ayala AG; Ro JY
    Arch Pathol Lab Med; 2007 Aug; 131(8):1244-56. PubMed ID: 17683187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
    Burger M
    Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704
    [No Abstract]   [Full Text] [Related]  

  • 36. MicroRNA and urothelial cell carcinoma.
    Miah S; Pang K; Catto JW
    BJU Int; 2014 May; 113(5):811-2. PubMed ID: 24552448
    [No Abstract]   [Full Text] [Related]  

  • 37. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinflunine: a new microtubule inhibitor agent.
    Bennouna J; Delord JP; Campone M; Nguyen L
    Clin Cancer Res; 2008 Mar; 14(6):1625-32. PubMed ID: 18347163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and cytogenetic events in urologic tumors.
    Klein EA; Fair WR; Chaganti RS
    Semin Urol; 1988 Feb; 6(1):2-21. PubMed ID: 2838875
    [No Abstract]   [Full Text] [Related]  

  • 40. [High response rates for erdafitinib in patients with FGFR-mutated urothelial carcinoma following failure of platinum-based chemotherapy].
    Grülllich C
    Urologe A; 2020 Apr; 59(4):478-479. PubMed ID: 32103289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.